In silico study on the heterogeneity of the dose distribution and radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy

被引：0
|
作者：
Birindelli, G. [1 ]
Drobnjakovic, M. [1 ]
Morath, V. [2 ]
Steiger, K. [3 ]
D'Alessandria, C. [2 ]
Gourni, E. [1 ]
Afshar-Oromieh, A. [1 ]
Weber, W. [2 ]
Rominger, A. [1 ]
Eiber, M. [2 ]
Shi, K. [1 ]
机构：
[1] Univ Bern, Inselspital, Bern, Switzerland
[2] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany
[3] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0049
引用
收藏
页码：S24 / S25
页数：2
相关论文
共 27 条
  • [1] In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy
    Birindelli, Gabriele
    Drobnjakovic, Milos
    Morath, Volker
    Steiger, Katja
    D'Alessandria, Calogero
    Gourni, Eleni
    Afshar-Oromieh, Ali
    Weber, Wolfgang
    Rominger, Axel
    Eiber, Matthias
    Shi, Kuangyu
    2021 43RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY (EMBC), 2021, : 4497 - 4500
  • [2] Ac-225/Lu-177 Radiotheranostics
    Zhang, Jingjing
    CANCER SCIENCE, 2025, 116 : 178 - 178
  • [3] Comparison of Administered Lu-177 and Ac-225 Activities of PSMA Treatments Against Metastatic Prostate Cancer: Radiobiological Factors
    Ahtiainen, V.
    Reijonen, V.
    Tenhunen, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S750 - S750
  • [4] Tandem PSMA Radioligand Therapy Using Ac-225 and Lu-177 in Advanced Prostate Cancer: Safety and Efficacy
    Kulkarni, H. R.
    Zhang, J.
    Singh, A.
    Mishra, A.
    Schuchardt, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S236 - S237
  • [5] Crown, a macrocyclic chelator for Lu-177, Bi-213, and Ac-225
    Yang, H.
    Wharton, L.
    Zhang, C.
    Benard, F.
    Radchenko, V.
    Schaffer, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S225 - S225
  • [6] DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy
    Graf, F.
    Fahrer, J.
    Maus, S.
    Morgenstern, A.
    Buchertseifer, F.
    Venkatachalam, S.
    Fottner, C.
    Weber, M.
    Huelsenbeck, J.
    Schreckenberger, M.
    Kaina, B.
    Miederer, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S107 - S107
  • [7] DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy
    Graf, Franziska
    Fahrer, Joerg
    Maus, Stephan
    Morgenstern, Alfred
    Bruchertseifer, Frank
    Venkatachalam, Senthil
    Fottner, Christian
    Weber, Matthias M.
    Huelsenbeck, Johannes
    Schreckenberger, Mathias
    Kaina, Bernd
    Miederer, Matthias
    PLOS ONE, 2014, 9 (02):
  • [8] Dose-dependent relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radionuclide therapy
    Rumiantcev, M.
    Li, W.
    Lindner, S.
    Liubchenko, G.
    Resch, S.
    Bartenstein, P.
    Ziegler, S.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S363 - S363
  • [9] Partial remission in thymic-NET with alpha-PRRT (Ac-225) refractory to beta-PRRT (Y-90/Lu-177)
    Singh, Aviral
    Kulkarni, Harshad R.
    Kreuzau, Julia
    Meister, Josephin
    Robiller, Franz Christoph
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 39 - 40
  • [10] Radioligand therapy using combination of Ac-225 and Lu-177 labelled PSMA ligands for progressive end-stage metastatic prostate cancer: effective trade-off between response and toxicity
    Kulkarni, Harshad
    Zhang, Jingjing
    Langbein, Thomas
    Schuchardt, Christiane
    Singh, Aviral
    Mueller, Dirk
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
123